258 filings
Page 5 of 13
DEFA14A
TSHA
Taysha Gene Therapies Inc
8 May 23
Additional proxy soliciting materials
4:04pm
DEF 14A
TSHA
Taysha Gene Therapies Inc
Definitive proxy
8 May 23
4:01pm
424B3
TSHA
Taysha Gene Therapies Inc
4 May 23
Prospectus supplement
4:02pm
EFFECT
TSHA
Taysha Gene Therapies Inc
2 May 23
Notice of effectiveness
12:15am
8-K
TSHA
Taysha Gene Therapies Inc
27 Apr 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:07pm
PRE 14A
TSHA
Taysha Gene Therapies Inc
27 Apr 23
Preliminary proxy
4:03pm
CORRESP
TSHA
Taysha Gene Therapies Inc
27 Apr 23
Correspondence with SEC
12:00am
UPLOAD
TSHA
Taysha Gene Therapies Inc
7 Apr 23
Letter from SEC
12:00am
S-3
TSHA
Taysha Gene Therapies Inc
Shelf registration
5 Apr 23
4:35pm
424B5
TSHA
Taysha Gene Therapies Inc
28 Mar 23
Prospectus supplement for primary offering
7:12pm
S-8
TSHA
Taysha Gene Therapies Inc
28 Mar 23
Registration of securities for employees
5:30pm
10-K
2022 FY
TSHA
Taysha Gene Therapies Inc
Annual report
28 Mar 23
4:58pm
8-K
TSHA
Taysha Gene Therapies Inc
28 Mar 23
Taysha Gene Therapies Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Corporate Update
4:12pm
4
TSHA
Taysha Gene Therapies Inc
8 Mar 23
Taysha Gene Therapies / R.A. Session II ownership change
7:38pm
8-K/A
TSHA
Taysha Gene Therapies Inc
8 Mar 23
Departure of Directors or Certain Officers
5:11pm
SC 13G/A
TSHA
Taysha Gene Therapies Inc
9 Feb 23
Taysha Gene Therapies / FMR ownership change
12:39pm
4
TSHA
Taysha Gene Therapies Inc
6 Feb 23
Taysha Gene Therapies / Kamran Alam ownership change
9:12pm
8-K
TSHA
Taysha Gene Therapies Inc
31 Jan 23
Taysha Gene Therapies Provides Update on TSHA-120 Program in Giant Axonal Neuropathy and a 2023 Corporate Outlook
4:09pm
8-K
TSHA
Taysha Gene Therapies Inc
19 Jan 23
Departure of Directors or Certain Officers
4:02pm